Teh Boon Lin, Megaw Roly, Borooah Shyamanga, Dhillon Baljean
Royal Infirmary of Edinburgh, Edinburgh, UK.
Princess Alexandra Eye Pavilion, Edinburgh, UK.
Surv Ophthalmol. 2017 May-Jun;62(3):346-356. doi: 10.1016/j.survophthal.2016.12.003. Epub 2016 Dec 22.
Age-related macular degeneration (AMD) is one of the leading causes of visual impairment. The development of cataract in AMD patients poses challenges in assessing timing of surgery, predicting potential benefit to the patient of surgery, and predicting short- and long-term effects of surgery on progression of their AMD. Although traditional cataract surgery remains the mainstay of treatment, recently several devices have been developed to address the specific needs of AMD patients with cataract. We look at the associations between cataract and AMD and outline the treatment approaches to cataract surgery in AMD, looking at the potential benefits and risks of both traditional approaches and newer devices. We provide clinicians treating patients with AMD and cataract with a framework for choosing the appropriate management.
年龄相关性黄斑变性（AMD）是视力损害的主要原因之一。AMD患者白内障的发展给评估手术时机、预测手术对患者的潜在益处以及预测手术对其AMD进展的短期和长期影响带来了挑战。尽管传统的白内障手术仍然是主要的治疗方法，但最近已经开发了几种设备来满足患有白内障的AMD患者的特殊需求。我们探讨白内障与AMD之间的关联，并概述AMD患者白内障手术的治疗方法，同时审视传统方法和新型设备的潜在益处和风险。我们为治疗AMD和白内障患者的临床医生提供一个选择合适治疗方案的框架。
